Alexandra Lawrence
Overview
Explore the profile of Alexandra Lawrence including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lei J, Cuschieri K, Patel H, Lawrence A, Deats K, Sasieni P, et al.
PLoS Med
. 2024 Dec;
21(12):e1004494.
PMID: 39666756
Background: Human papillomavirus (HPV) testing of self-collected vaginal samples has potential to improve coverage of cervical screening programmes, but current guidelines mostly require those HPV positive on a self-sample to...
2.
Shaw G, Lilly M, Mai V, Clark J, Summers S, Slater K, et al.
R Soc Open Sci
. 2024 Nov;
11(11):240837.
PMID: 39507992
Habitat loss and forest fragmentation are often linked to increased pathogen transmission, but the extent to which habitat isolation and landscape connectivity affect disease dynamics through movement of disease vectors...
3.
Lim A, Deats K, Gambell J, Lawrence A, Lei J, Lyons M, et al.
EClinicalMedicine
. 2024 Oct;
73:102672.
PMID: 39429813
Background: Self-sampling has game-changing potential to tackle the declining participation and inequities seen in many organised cervical screening programmes. Wide variation in uptake between settings and mode of kit offer...
4.
Lawrence A, Myall K, Mukherjee B, Marino P
Life (Basel)
. 2024 Sep;
14(9).
PMID: 39337985
Pulmonary hypertension (PH) in interstitial lung disease (ILD) is relatively common, affecting up to 50% of patients with idiopathic pulmonary fibrosis (IPF). It occurs more frequently in advanced fibrotic ILD,...
5.
Naqvi M, Hannah J, Lawrence A, Myall K, West A, Chaudhuri N
Expert Rev Respir Med
. 2024 Jul;
18(6):397-407.
PMID: 39039699
Introduction: Progressive pulmonary fibrosis (PPF) is a manifestation of a heterogenous group of underlying interstitial lung disease (ILD) diagnoses, defined as non-idiopathic pulmonary fibrosis (IPF) progressive fibrotic ILD meeting at...
6.
Dixon G, Hague S, Mulholland S, Adamali H, Khin A, Thould H, et al.
ERJ Open Res
. 2024 Jan;
10(1).
PMID: 38226064
Background: Nintedanib slows progression of lung function decline in patients with progressive fibrosing (PF) interstitial lung disease (ILD) and was recommended for this indication within the United Kingdom (UK) National...
7.
Hannah J, Lawrence A, Martinovic J, Naqvi M, Chua F, Kouranos V, et al.
Rheumatology (Oxford)
. 2023 Dec;
63(11):3080-3090.
PMID: 38039151
Objectives: The impact of autoantibody profiles on the prognosis for idiopathic inflammatory myositis-associated interstitial lung disease (IIM-ILD) and myositis spectrum ILD with myositis-specific antibodies (MSAs) remains unclear. This retrospective cohort...
8.
Gaba F, Blyuss O, Chandrasekaran D, Bizzarri N, Refky B, Barton D, et al.
Diagnostics (Basel)
. 2023 Nov;
13(22).
PMID: 37998621
For women achieving clinical remission after the completion of initial treatment for epithelial ovarian cancer, 80% with advanced-stage disease will develop recurrence. However, the standard treatment of women with recurrent...
9.
Brincat M, Mira A, Lawrence A
Diagnostics (Basel)
. 2023 Nov;
13(21).
PMID: 37958227
Tubo-ovarian cancer is the most lethal gynaecological cancer. More than 75% of patients are diagnosed at an advanced stage, which is associated with poorer overall survival. Symptoms at presentation are...
10.
Ricci L, Di Musciano M, Sabatini F, Chiarucci A, Zannini P, Gatti R, et al.
Conserv Biol
. 2023 Oct;
38(3):e14212.
PMID: 37904665
The Natura 2000 (N2K) protected area (PA) network is a crucial tool to limit biodiversity loss in Europe. Despite covering 18% of the European Union's (EU) land area, its effectiveness...